Cetera Investment Advisers
FBIO icon

Cetera Investment Advisers’s Fortress Biotech FBIO Stock Holding History

Cetera Investment Advisers’s Portfolio FBIO Stock Details FBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-39,151
Closed -$72.8K – 4603
2025
Q2 		$72.8K Sell
39,151
-7,458
-16% -$12.9K ﹤0.01% 3932
2025
Q1 		$72.7K Buy
46,609
+23,929
+106% +$42.2K ﹤0.01% 3819
2024
Q4 		$45.9K Buy
22,680
+3,691
+19% +$6.69K ﹤0.01% 3661
2024
Q3 		$27.4K Buy
18,989
+2,223
+13% +$4.23K ﹤0.01% 3635
2024
Q2 		$28.7K Buy
16,766
+1,012
+6% +$1.83K ﹤0.01% 3628
2024
Q1 		$31.5K Buy
15,754
+2,315
+17% +$4.61K ﹤0.01% 3608
2023
Q4 		$40.5K Buy
+13,439
New +$35.5K ﹤0.01% 2175
2023
Q1 		– Sell
-1,567
Closed -$15.4K – 2190
2022
Q4 		$15.4K Buy
1,567
+698
+80% +$7.72K ﹤0.01% 2068
2022
Q3 		$11K Buy
+869
New +$13K ﹤0.01% 1652

Other funds holding FBIO

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SF
Summit Financial Parsippany, New Jersey $9.12B AUM 27.44% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return
SAM
Shikiar Asset Management New York $396M AUM 41.06% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
SC
Sculptor Capital New York $12.3B AUM 40.26% 1-Year Est. Return
KAS
Kestra Advisory Services Austin, Texas $31B AUM 28.39% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
HWM
HB Wealth Management Atlanta, Georgia $17.8B AUM 24.16% 1-Year Est. Return

Cetera Investment Advisers's FBIO Position: Q3 2025 in Review

Cetera Investment Advisers sold out of Fortress Biotech (FBIO) in Q3 2025, closing a stake of 39,151 shares — an estimated $72.8K sold.

Cetera Investment Advisers first reported a position in FBIO in Q3 2022 and held it in 9 quarters. The position peaked at $72.8K in Q2 2025. 56 funds tracked by Wall St. Rank hold FBIO as of Q3 2025.

  • Cetera Investment Advisers reported no remaining Fortress Biotech position as of Q3 2025 after selling out during the quarter.
  • Cetera Investment Advisers sold 39,151 Fortress Biotech shares in Q3 2025, an estimated $72.8K.
  • Cetera Investment Advisers first reported a position in Fortress Biotech in Q3 2022 and held it in 9 quarters.
  • Cetera Investment Advisers's Fortress Biotech position peaked at $72.8K in Q2 2025.
  • 56 funds tracked by Wall St. Rank held Fortress Biotech as of Q3 2025.

Based on Cetera Investment Advisers's 13F filing for Q3 2025, filed 14 Nov 2025.